Cargando…
Clinical Effectiveness of a Protocol to Manage Deamthasone-Induced Hyperglycemia Among Hospitalized Patients With COVID-19
Importance: Well-controlled glucose levels during hospitalization (i.e. 70–180 mg/dl) have been associated with lower mortality in patients with COVID-19. The recent addition of dexamethasone to COVID-19 treatment protocols has raised concerns about the negative metabolic consequences of dexamethaso...
Autores principales: | Asiri, Alanood Ahmed, AlGuwaihes, Abdullah, Jammah, Anwar Ali, Alfadda, Assim Abdulaziz, Al-Sofiani, Mohammed E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135499/ http://dx.doi.org/10.1210/jendso/bvab048.687 |
Ejemplares similares
-
Assessment of the Effectiveness of a Protocol to Manage Dexamethasone-Induced Hyperglycemia Among Hospitalized Patients With COVID-19
por: Asiri, Alanood A., et al.
Publicado: (2021) -
ODP608 Quality of Life and Treatment Satisfaction in Patients with Type 1 Diabetes Experiencing Different Models of Care in Saudi Arabia
por: Aldeeri, Ibraheem, et al.
Publicado: (2022) -
LBODP031 Evaluation Of Artifactual Hypoglycemia: A Case-based Review
por: Mohammed ALShehri, Sara, et al.
Publicado: (2022) -
SUN-163 Implementation of a Protocol for the Management of Steroid-Induced Hyperglycemia
por: Khan, Mahmuda, et al.
Publicado: (2019) -
Phosphoinositide 3-Kinase Inhibitor-Induced Hyperglycemia
por: Shey, Susan, et al.
Publicado: (2021)